Active ingredient
Orforglipron
6 finished FDA listings contain Orforglipron as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- ORFORGLIPRON, ORFORGLIPRON CALCIUM
- Dosage forms
- Tablet, Film Coated
- Routes
- Oral
- Manufacturers / labelers
- 1
- Strengths listed
- .8 mg/1 · 14.5 mg/1 · 17.2 mg/1 · 2.5 mg/1 · 5.5 mg/1 · 9 mg/1
- Brand names in FDA listings
- Foundayo
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2739838
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 220934 | ELI LILLY AND CO | 2026-04-01 | 6 |
Official labeling on DailyMed
- FOUNDAYO (ORFORGLIPRON) TABLET, FILM COATED [ELI LILLY AND COMPANY] · version 10 · 2026-08-13
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.